NU SKIN ENTERPRISES, INC.NUS
時価総額
$5億
PER
美容・ウェルネス製品の大手。直販とソーシャルコマースを軸としたサブスク型販売体制を展開。2023年4月にLifeDNAを60%取得、同年6月にBeautyBioを7500万ドルで買収。米国・中国・韓国・日本を中心とする約50市場での展開。
| 2010年 12月31日 | 2011年 12月31日 | 2012年 12月31日 | 2013年 12月31日 | 2014年 12月31日 | 2015年 12月31日 | 2016年 12月31日 | 2017年 12月31日 | 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | 2023年 12月31日 | 2024年 12月31日 | |
| Cash and cash equivalents | 230 | 273 | 320 | 525 | 288 | 289 | 357 | 426 | 387 | 336 | 403 | 340 | 265 | 256 | 187 |
| Current investments | - | 18 | 13 | 22 | 12 | 14 | 11 | 12 | 11 | 8 | 21 | 15 | 14 | 12 | 11 |
| Accounts receivable, net | - | - | - | - | - | - | - | - | - | - | 63 | 41 | 47 | 73 | 51 |
| Inventories, net | 114 | 112 | 136 | 340 | 338 | 265 | 250 | 253 | 296 | 276 | 314 | 400 | 346 | 280 | 190 |
| Prepaid expenses and other | - | - | - | - | 160 | 102 | 65 | 53 | 52 | 70 | 102 | 77 | 88 | 81 | 73 |
| Total current assets held for sale | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 27 |
| Total current assets | 423 | 530 | 599 | 1,118 | 835 | 706 | 714 | 778 | 799 | 740 | 903 | 873 | 760 | 702 | 539 |
| Property and equipment, net | 134 | 150 | 230 | 396 | 465 | 455 | 445 | 465 | 465 | 454 | 468 | 454 | 445 | 433 | 380 |
| Operating lease right-of-use assets | - | - | - | - | - | - | - | - | - | 144 | 155 | 121 | 99 | 90 | 73 |
| Goodwill | 112 | 112 | 112 | 112 | 112 | 112 | 115 | 115 | 197 | 197 | 203 | 206 | 206 | 231 | 84 |
| Other intangible assets, net | - | 83 | 93 | 83 | 75 | 67 | 64 | 68 | 90 | 80 | 90 | 77 | 67 | 105 | 74 |
| Other assets | 145 | 116 | 119 | 111 | 127 | 165 | 136 | 165 | 144 | 154 | 138 | 175 | 244 | 245 | 298 |
| Total long-term assets held for sale | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 22 |
| Total assets | 892 | 991 | 1,153 | 1,821 | 1,614 | 1,506 | 1,474 | 1,590 | 1,694 | 1,769 | 1,957 | 1,906 | 1,821 | 1,806 | 1,469 |
| Accounts payable | 25 | 32 | 48 | 83 | 35 | 29 | 41 | 50 | 48 | 39 | 66 | 50 | 54 | 44 | 35 |
| Accrued expenses | 146 | 180 | 233 | 626 | 301 | 311 | 275 | 319 | 323 | 290 | 447 | 372 | 280 | 260 | 218 |
| Current portion of long-term debt | 28 | 29 | 39 | 68 | 83 | 68 | 83 | 78 | 69 | 28 | 30 | 108 | 25 | 25 | 30 |
| Total current liabilities held for sale | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 14 |
| Total current liabilities | 216 | 241 | 320 | 777 | 418 | 408 | 399 | 447 | 440 | 357 | 543 | 530 | 359 | 329 | 297 |
| Operating lease liabilities | - | - | - | - | - | - | - | - | - | 106 | 112 | 89 | 77 | 71 | 58 |
| Long-term debt | 133 | 108 | 155 | 114 | 165 | 182 | 334 | 311 | 361 | 334 | 305 | 269 | 377 | 478 | 364 |
| Other liabilities | 72 | 68 | 87 | 72 | 89 | 91 | 77 | 127 | 112 | 97 | 102 | 106 | 110 | 107 | 97 |
| Total long-term liabilities held for sale | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1 |
| Total liabilities | 421 | 417 | 562 | 962 | 672 | 680 | 810 | 885 | 913 | 894 | 1,063 | 994 | 924 | 984 | 817 |
| Class A common stock - 500 million shares authorized, $0.001 par value, 90.6 million shares issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Additional paid-in capital | 257 | 292 | 317 | 397 | 414 | 420 | 440 | 466 | 553 | 558 | 580 | 602 | 613 | 622 | 628 |
| Treasury stock, at cost - 40.8 million and 41.1 million shares | - | - | - | - | - | - | - | - | - | - | - | 1,527 | 1,569 | 1,570 | 1,564 |
| Accumulated other comprehensive loss | -59 | -63 | -52 | -46 | -52 | -71 | -84 | -66 | -80 | -85 | -65 | -74 | -87 | -100 | -125 |
| Retained earnings | 750 | 867 | 1,040 | 1,334 | 1,442 | 1,494 | 1,559 | 1,609 | 1,636 | 1,728 | 1,841 | 1,912 | 1,939 | 1,870 | 1,712 |
| Total stockholders' equity | 471 | 574 | 591 | 859 | 942 | 826 | 664 | 705 | 782 | 875 | 894 | 913 | 897 | 822 | 651 |
| Total liabilities and stockholders' equity | 892 | 991 | 1,153 | 1,821 | 1,614 | 1,506 | 1,474 | 1,590 | 1,694 | 1,769 | 1,957 | 1,906 | 1,821 | 1,806 | 1,469 |